NOTCH3 p.R544C Drives Early Neurovascular Unit Dysfunction through Blood-Brain Barrier Failure, Complement Signalling and Metabolic Dysregulation
Cerebral small vessel disease is a major cause of stroke and vascular cognitive impairment, yet the mechanisms that initiate neurovascular dysfunction before irreversible brain injury remain poorly defined. CADASIL, caused by cysteine-altering NOTCH3 mutations, provides a genetically tractable model to resolve these early events. Here, we investigated the Asian-enriched NOTCH3 p.R544C variant and tested whether early disease emerges through interconnected blood-brain barrier (BBB), inflammatory, and metabolic dysfunction. NOTCH3 p.R544C iPSC-derived endothelial cells showed impaired angiogenesis and migration, reduced barrier resistance, disrupted tight-junction organisation, and altered vascular, adhesion, and extracellular-matrix programmes. In multicellular BBB-like microtissues, these defects propagated across the neurovascular unit, producing disorganised vascular networks, enlarged luminal structures, and increased permeability, establishing BBB failure as an early disease layer. Single-cell transcriptomics revealed coordinated loss of endothelial BBB transport and efflux programmes with astrocytic complement, innate immune, and matrix-remodelling activation. Secretome profiling and patient-plasma measurements converged on complement- and matrix-associated mediators, including C1S and CLU, identifying complement-matrix activation as a second interconnected layer. Importantly, combined cilostazol and isosorbide mononitrate treatment improved barrier function and reduced selected complement- and matrix-associated proteins in mutant microtissues, supporting pharmacological reversibility of components of this early disease programme. Seahorse analysis further demonstrated reduced mitochondrial respiratory capacity associated with NOTCH3 p.R544C. In vivo, three-month-old mutant mice showed altered cerebral pyruvate metabolism and early microvascular abnormalities, whereas six-month-old mice developed more prominent extracellular-matrix, inflammatory, and gliovascular changes, supporting an age-dependent transition from early metabolic dysregulation to broader neurovascular remodelling. Together, these findings define NOTCH3 p.R544C CADASIL as an early multicellular neurovascular disorder organised across three interconnected mechanistic layers: BBB failure, complement-matrix signalling, and metabolic dysregulation, while identifying early BBB-centred dysfunction as a potentially tractable state before advanced cerebrovascular injury develops.
Authors
- Christine Cheung (ORCID: https://orcid.org/0000-0001-7127-9107)
- Jolene Wei Ling Lee (ORCID: https://orcid.org/0009-0000-8644-7839)
- Adeline Su Lyn Ng (ORCID: https://orcid.org/0000-0001-8822-8496)
- Alicia Qian Ler Tan (ORCID: https://orcid.org/0000-0001-9298-4008)
- Laurie H. Sanders (ORCID: https://orcid.org/0000-0003-1617-9562)
- Eng‐King Tan (ORCID: https://orcid.org/0000-0003-2977-9743)
- Li Zeng (ORCID: https://orcid.org/0000-0003-3242-2286)
- Zhen‐Kai Ngian (ORCID: https://orcid.org/0000-0002-4134-2846)
- Qunxiang Ong (ORCID: https://orcid.org/0000-0003-3674-2105)
- Pei Zhong (ORCID: https://orcid.org/0000-0002-2368-6151)
- Zhiwei Zhang (ORCID: https://orcid.org/0000-0002-6131-3233)
- Monika Chauhan (ORCID: https://orcid.org/0000-0001-8564-5454)
- Xing Qi Teo
- Tse Siew Lim
- Hannah Su-Ann Wee
Institutions
- Agency for Science, Technology and Research (SG)
- Sun Yat-sen University (CN)
- Duke University (US)
- National Neuroscience Institute (SG)
Publication Details
- Journal
- bioRxiv (Cold Spring Harbor Laboratory)
- Published
- 2026-11-20
- DOI
- https://doi.org/10.64898/2026.11.17.767474
- Primary Topic
- Barrier Structure and Function Studies
- Type
- preprint